Skip to main content
. 2015 Aug 20;128(16):2147–2153. doi: 10.4103/0366-6999.162498

Table 5.

Comparison of adverse events between OSAHS and non-OSAHS patients after anticoagulation cessation (n (%))

Events OSAHS (n = 28) Non-OSAHS (n = 59) Total (n = 87) P
PE recurrence 6 (21.43) 4 (6.78) 10 (11.49) 0.047
Heart failure 0 2 (3.39) 2 (2.30) 0.209
Death 2 (7.14) 3 (5.08) 5 (5.75) 0.705
Others 0 1 (1.70) 1 (1.15) 0.376
Total incidence 8 (28.57) 10 (16.95) 18 (20.69) 0.214

OSAHS: Obstructive sleep apnea hypopnea syndrome; PE: Pulmonary embolism.